SC
KYNB

Steven Cohen’s Kyntra Bio KYNB Stock Holding History

Steven Cohen’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,211
Closed -$2.54M – 2032
2024
Q1 		$2.54M Buy
+43,211
New +$1.86M 0.01% 1184
2023
Q4 		– Sell
-527
Closed -$7.95K – 2355
2023
Q3 		$11.4K Buy
+527
New +$20.7K ﹤0.01% 2327
2023
Q2 		– Sell
-137,057
Closed -$56.7M – 2371
2023
Q1 		$63.9M Sell
137,057
-54,209
-28% -$28.7M 0.2% 127
2022
Q4 		$76.6M Buy
191,266
+158
+0.1% +$60.5K 0.26% 97
2022
Q3 		$62.2M Sell
191,108
-11,544
-6% -$3.72M 0.25% 104
2022
Q2 		$53.5M Sell
202,652
-30,634
-13% -$7.83M 0.23% 115
2022
Q1 		$70.1M Buy
233,286
+83,982
+56% +$29.3M 0.28% 91
2021
Q4 		$52.6M Buy
149,304
+104,860
+236% +$32.6M 0.21% 127
2021
Q3 		$11.4M Buy
+44,444
New +$15.7M 0.05% 455

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steven Cohen's KYNB Position: Q2 2024 in Review

Steven Cohen sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 43,211 shares — an estimated $2.54M sold.

Steven Cohen first reported a position in KYNB in Q3 2021 and held it in 9 quarters. The position peaked at $76.6M in Q4 2022. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Steven Cohen reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Steven Cohen sold 43,211 Kyntra Bio shares in Q2 2024, an estimated $2.54M.
  • Steven Cohen first reported a position in Kyntra Bio in Q3 2021 and held it in 9 quarters.
  • Steven Cohen's Kyntra Bio position peaked at $76.6M in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.